FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366393619> ?p ?o ?g. }

• W4366393619 endingPage "842" @default.
• W4366393619 startingPage "832" @default.
• W4366393619 abstract "The overall goal of this report is to provide a high-level, practical approach to managing venous outflow obstruction (VOO) in Australia and New Zealand.A group of vascular surgeons from the Australian and New Zealand Society for Vascular Surgery with specific interest, training, and experience in the management of VOO were surveyed to assess current local practice. The results were analyzed and areas of disagreement identified. Following this, the group performed a literature review of consensus guidelines published by leading international organizations focused on the management of chronic venous disease, namely the Society for Vascular Surgery, American Venous Forum, European Society for Vascular Surgery, American Vein and Lymphatic Society, Cardiovascular and Interventional Radiology Society of Europe, and American Heart Association. These guidelines were compared against the consensus statements obtained through the surveys to determine how they relate to Australian and New Zealand practice. In addition, selected key studies, reviews, and meta-analyses on venous stenting were discussed and added to the document. Finally, a selection of statements with >75% agreement was voted on, and barriers to the guideline's applicability were identified.The document addresses two key areas: patient selection and technical aspects of venous stenting. Regarding patient selection, patients with a CEAP (Clinical-Etiologic-Anatomic-Physiologic) score of ≥3 or a venous clinical severity score for pain of ≥2, or both, and evidence of >50% stenosis on venography, computed tomography venography, magnetic resonance venography, and/or intravascular ultrasound should be considered for venous stenting (level of recommendation Ib) Patients undergoing thrombus removal for acute iliofemoral deep vein thrombosis, in whom a culprit stenotic lesion has been uncovered, should be considered for venous stenting (level of recommendation Ib). Patients with chronic pelvic pain, deep dyspareunia, postcoital pain affecting their quality of life, when other causes have been ruled out, should be considered for venous stenting (level of recommendation Ic). Asymptomatic patients should not be offered venous stenting (level of recommendation IIIc).Patients with deep VOO have been underdiagnosed and undertreated for decades; however, in recent years, interest from physicians and industry has grown substantially. The advent of simpler and safer treatment options has revolutionized its management, but, unfortunately, formal training for venous disease has not grown at the same rate. Simplifying the technology and training required can result in inconsistent outcomes. These guidelines are aimed at developing standards of care and will serve as an educational platform for future developments." @default.
• W4366393619 created "2023-04-21" @default.
• W4366393619 creator A5052477051 @default.
• W4366393619 creator A5052949721 @default.
• W4366393619 creator A5069567129 @default.
• W4366393619 creator A5071935834 @default.
• W4366393619 creator A5076902523 @default.
• W4366393619 creator A5086028209 @default.
• W4366393619 creator A5087616988 @default.
• W4366393619 creator A5091024247 @default.
• W4366393619 date "2023-07-01" @default.
• W4366393619 modified "2023-09-27" @default.
• W4366393619 title "Australian and New Zealand Society for Vascular Surgery clinical practice guidelines on venous outflow Obstruction of the femoral-iliocaval veins" @default.
• W4366393619 cites W1660368145 @default.
• W4366393619 cites W1664566016 @default.
• W4366393619 cites W1965821124 @default.
• W4366393619 cites W1971018109 @default.
• W4366393619 cites W1976024392 @default.
• W4366393619 cites W1984515787 @default.
• W4366393619 cites W1989173024 @default.
• W4366393619 cites W1995447870 @default.
• W4366393619 cites W2008165633 @default.
• W4366393619 cites W2009029375 @default.
• W4366393619 cites W2010293741 @default.
• W4366393619 cites W2011859830 @default.
• W4366393619 cites W2022949104 @default.
• W4366393619 cites W2030745749 @default.
• W4366393619 cites W2038609386 @default.
• W4366393619 cites W2047384553 @default.
• W4366393619 cites W2054816078 @default.
• W4366393619 cites W2059030693 @default.
• W4366393619 cites W2066240141 @default.
• W4366393619 cites W2082112819 @default.
• W4366393619 cites W2104174675 @default.
• W4366393619 cites W2104431019 @default.
• W4366393619 cites W2107941853 @default.
• W4366393619 cites W2120412915 @default.
• W4366393619 cites W2123960644 @default.
• W4366393619 cites W2141548210 @default.
• W4366393619 cites W2142589152 @default.
• W4366393619 cites W2155162963 @default.
• W4366393619 cites W2191131250 @default.
• W4366393619 cites W2201105820 @default.
• W4366393619 cites W2524948066 @default.
• W4366393619 cites W2564649121 @default.
• W4366393619 cites W2737059521 @default.
• W4366393619 cites W2761300508 @default.
• W4366393619 cites W2766051783 @default.
• W4366393619 cites W2777708233 @default.
• W4366393619 cites W2778859021 @default.
• W4366393619 cites W2789819411 @default.
• W4366393619 cites W2792716857 @default.
• W4366393619 cites W2792948742 @default.
• W4366393619 cites W2793731849 @default.
• W4366393619 cites W2888364199 @default.
• W4366393619 cites W2901947158 @default.
• W4366393619 cites W2918941540 @default.
• W4366393619 cites W2953021046 @default.
• W4366393619 cites W2956101838 @default.
• W4366393619 cites W2987037506 @default.
• W4366393619 cites W3007080699 @default.
• W4366393619 cites W3010036717 @default.
• W4366393619 cites W3016749718 @default.
• W4366393619 cites W3037698801 @default.
• W4366393619 cites W3048748582 @default.
• W4366393619 cites W3054903919 @default.
• W4366393619 cites W3126901034 @default.
• W4366393619 cites W3127728920 @default.
• W4366393619 cites W3139343748 @default.
• W4366393619 cites W3154209317 @default.
• W4366393619 cites W3161683879 @default.
• W4366393619 cites W3194121077 @default.
• W4366393619 cites W3201004551 @default.
• W4366393619 cites W3214044289 @default.
• W4366393619 cites W4205529280 @default.
• W4366393619 cites W4205760379 @default.
• W4366393619 cites W4206813711 @default.
• W4366393619 cites W4206953934 @default.
• W4366393619 cites W4225676825 @default.
• W4366393619 cites W4251900443 @default.
• W4366393619 cites W4280586947 @default.
• W4366393619 cites W4286268907 @default.
• W4366393619 cites W4286435166 @default.
• W4366393619 cites W4291708269 @default.
• W4366393619 doi "https://doi.org/10.1016/j.jvsv.2023.02.002" @default.
• W4366393619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37085086" @default.
• W4366393619 hasPublicationYear "2023" @default.
• W4366393619 type Work @default.
• W4366393619 citedByCount "1" @default.
• W4366393619 countsByYear W43663936192023 @default.
• W4366393619 crossrefType "journal-article" @default.
• W4366393619 hasAuthorship W4366393619A5052477051 @default.
• W4366393619 hasAuthorship W4366393619A5052949721 @default.
• W4366393619 hasAuthorship W4366393619A5069567129 @default.
• W4366393619 hasAuthorship W4366393619A5071935834 @default.
• W4366393619 hasAuthorship W4366393619A5076902523 @default.
• W4366393619 hasAuthorship W4366393619A5086028209 @default.
• W4366393619 hasAuthorship W4366393619A5087616988 @default.

• next